Our9Ja Trending News
Coronavirus (COVID-19) Health News

Favipiravir – All You Need To Know About The New COVID-19 Drug & Its Effects

Favipiravir is an anti-viral drug which is currently being tested in 18 clinical trials for COVID-19 Drugs and results from two studies have shown a positive outcome.

Mumbai-based Glenmark Pharmaceuticals has received approvals from Drug Controller General of India to manufacture and market Favipiravir, an anti-viral drug, to treat Covid-19 patients. The drug is likely to be available in the market in the next few days. What is this drug and what improvement has it shown in Covid-19 patients?

What is Favipiravir?

Favipiravir is an anti-viral drug and it is approved in Japan for treating influenza. It is currently being tested in 18 clinical trials for COVID-19 Drug and results from two studies have shown a positive outcome, while data from other trials is awaited.

What is the Glenmark drug approved by the Drug Controller General of India?

Based on Phase-3 data, the company obtained approval for manufacture and marketing of antiviral drug Favipiravir, which has been branded as FabiFlu, an oral medication. The approval is for emergency restricted use only for treatment of mild to moderate Covid-19 patients. The approval’s restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation.

Favipiravir: All You Need To Know About The New COVID-19 Drug & Its Effects

According to a press release issued by Glenmark on Saturday, June 20, the company successfully developed the active pharmaceutical ingredient and formulation for FabiFlu through its own in-house R&D team.

“Glenmark filed the product for clinical trial with India’s drug regulator DCGI and became the first pharmaceutical company in India to receive approval for conducting phase 3 clinical trial on mild to moderate COVID-19 patients,” the press release said.

What improvement has it shown in COVID-19 patients and what studies has Glenmark cited?

Glenmark claimed that Favipiravir shows clinical improvements of up to 88 per cent in Covid-19, with rapid reduction in viral load by four days. The drug will be available as a prescription-based medication for Rs 103/tablet, with recommended dose being 1800 mg twice daily on day 1, followed by 800 mg twice daily up to day 14.

In India, a randomised multi-centre study was done on Indian patients to test the drug’s efficacy and safety with standard of care vs standard of care alone in mild to moderate Covid-19, the company said. The study enrolled 150 patients. The study’s details are yet to be published in a peer-reviewed paper.

In its press release, the company cited four studies; two from China and one reach from Russia and Japan. One of the studies done on 80 patients in China studied the efficacy of Favipiravir vis-à-vis anti-retroviral drugs Lopinavir and Ritonavir. Favipiravir treatment led to a quicker reduction in viral load compared to the other drugs. In the second Chinese study, 236 patients were enrolled.

Favipiravir showed a better rate of clinical recovery on seventh day compared Umifenovir, another antiviral drug. It also led to a quicker relief from fever and cough. The observational study in Japan comprising 2,141 patients with mild to moderate symptoms showed clinical improvement using Favipiravir.

Is the government conducting trials to test the efficacy of this drug?

Yes. The Council of Scientific and Industrial Research (CSIR) had done end-to-end synthesis of Favipiravir in April. Earlier this week, CSIR got approvals from DGCI to conduct multi-centre Phase-II trials of the drug.

© 2020, Our9Ja Trending News. All rights reserved. On republishing this post you must provide link to original post

Subscribe To Our WhatsApp Group For Latest News Directly To Your Mobile
Join WhatsApp News Group

Related posts

Fear grips Surulere residents as robbery gang “1 Million boys” sends letter to inform them that they are coming to their neighbourhood


Boko Haram Releases Video Execution Of Nigerian Soldier, Policeman


Nigeria COVID-19 Tolls Rise To 31,987 With 664 New Cases, 724 Deaths


Premier League Reveals September 12 Start Date For 2020/21 Season


Newspaper Vendors Protest Killing Of Their Colleague By House Of Reps Speaker, Gbajabiamila’s Security Aide


Elephant Rescued From Deep Well In A 14-Hour Operation [Video]


Dismissed & Serving Soldiers Arrested With 24 Sacks Of Indian Hemp In Lagos


Chinese Man Spends 2 Years Salary To Buy 99 iPhones Just To Propose And She Says NO


Nigerian COVID-19 Cases On The Rise Again As NCDC Confirmed 601 New Cases


1 comment

Man Stabs Wife To Death And Then Commits Suicide In Their Home June 22, 2020 at 9:38 am

[…] Favipiravir – All You Need To Know… […]


Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

Subscribe To Our WhatsApp Group For Latest News Directly To Your Mobile
Join WhatsApp News Group

Sucbrible For Latest News  Directly To Your Mobile

Join WhatsApp News Group
You can unsubscribe anytime.
Click Me